Chronic Condition Management

Despite the availability of new, highly successful direct-acting antiviral (DAA) regimens, more than one third of chronic hepatitis C (HCV) patients are denied access to treatment by their insurance provider, according to a new study.

For the White House to meet its goals on stopping the nation’s opioid crisis, there are some practical steps to put in place first.

Treatment with a combination of ledipasvir and sofosbuvir can lead to large economic gains.

Clinicians need to carefully plan treatment when prescribing DAA therapy for patients infected with hepatitis C virus who have hepatocellular carcinoma.

All hepatitis C virus genotypes respond to therapy

Recipients of hepatitis C-infected kidneys treated with direct-acting antiviral agents are disease-free one year post-transplant.

More patients could take advantage of shorter direct-acting antiviral treatment duration.

Females, Hispanics screened less often for highly curable infection.

With the advent of new direct-acting antiviral agents, HCV treatment has greatly improved, making identification of infected individuals even more imperative.

More effort needed to integrate screening with follow-up care to prevent spread of the virus.

Less than 10% of eligible COPD patients were referred to pulmonary rehabilitation programs, according to a new UK study.

Long-thought to be primarily caused by smoking and other exposures, scientists now believe that congenital changes to lung tissues with a genetic link may also be to blame.

Hispanic and Asian patients have a higher risk of cirrhosis and liver cancer, but direct-antiviral treatment eliminates ethnic disparities.

Those using illicit drugs and co-infected with HIV and hepatitis C are willing to use direct-acting anti-viral agents, says a new study.

Study: Certain bronchodilators may lead to an increased risk of cardiovascular disease in COPD patients at onset of starting therapy.

Tailored health coaching services can help keep COPD patients moving and avoid exacerbations, according to a new report.

Targeted efforts may improve the reach of treatment with direct-acting antiviral agents, according to a new study.

Researchers: Treatment-naïve patients infected with genotype 1 hepatitis C virus can receive shorter regimen.

A recent study may be first of its kind to report association while also highlights an interesting gender difference in patients.

U.K. study reveals that individuals who maintain a 10- to 30-pound weight loss might achieve diabetes remission, but U.S. authorities question such strict dieting.

Insulin was invented to be affordable for most everyone, but patients continue to struggle for a key part of treating their diabetes.

Physicians can help patients plan and manage holiday temptation so a few days of indulgence doesn’t turn into a new normal in the new year.

An innovative telemedicine model could substantially reduce the burden of chronic hepatitis C infection.

Timely treatment with direct-acting antivirals is highly cost-effective in virtually all patients infected with HCV.

Week 4 HCV RNA levels have implications for treatment with direct-acting antiviral agents for hepatitis C virus infections.

The benefits of HCV treatment will need to extend to all patients in order to stem the rising tide of HCV complications among women and men.

Direct-acting antiviral therapy with sofosbuvir-based combinations safely and effectively treats HCV infection in patients with early-stage chronic kidney disease.

A new study suggests a public health approach is necessary to control the spread of hepatitis C virus in urban communities.

Liver transplant outcomes have improved following the introduction of new hepatitis C virus drugs, according to a new study.

Primary care professionals can “substantially expand” HCV treatment in the community, according to new research.